The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
Harbin Pharmaceutical losses RMB1.17bln on investment in GNC Holding
Chinese drugmaker Harbin Pharmaceutical Group Co.,Ltd. (600664.SH) announced late Sunday that its investment in GNC Holdings, Inc. (GNC) of the United States had caused a loss of 1.165 billion yuan.
June22,2020
Hayao picks 40pct stake in GNC, to also form new JV
Harbin Pharmaceutical Group Holding Co Ltd, better known as Hayao, said it will invest about 300 million U.S. dollars in GNC Holdings Inc, potentially becoming the single largest shareholder in the US company with a 40-percent stake.
February26,2018
GNC names Ken Martindale new CEO
GNC Holdings, Inc. named Ken Martindale its new CEO, succeeding interim CEO Bob Moran.
September07,2017
If you have any questions, please enter them in the box below.
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.
